General Information

Iohexol Impurities and Iohexol

Daicel Pharma synthesizes top-notch impurity standards for Iohexol, an active pharmaceutical ingredient. We offer crucial impurity standards such as EP IOHEXOL IMPURITY F/ Iohexol impurity F, EP IOHEXOL IMPURITY M/ Iohexol impurity M, IOHEXOL EP IMPURITY G/ Iohexol Impurity G, IOHEXOL EP IMPURITY H/ Iohexol Impurity H, and IOHEXOL EP IMPURITY I/ Iohexol Impurity I, which play a vital role in evaluating the purity, and safety of Iohexol. Daicel Pharma also provides a custom synthesis of Iohexol impurity standards to meet specific client needs and worldwide delivery options.

In various radiographic procedures, Iohexol [CAS: 66108-95-0] is an effective non-ionic water-soluble X-ray contrast medium used in radiographic procedures. It is for myelography, arthrography, nephroangiography, arteriography, and other similar methods. The concentration of Iohexol in the medium varies from 140 to 350 milligrams of iodine per milliliter.

Iohexol: Use and Commercial Availability  

Omnipaque 12, Omnipaque 140, Oraltag, etc., are the brands that contain Iohexol. Iohexol is a safe, non-ionic, low osmolar contrast agent with a molecular weight of 821 Da. Its eliminated by kidneys through filtration. It does not undergo metabolism, secretion, or reabsorption. Iohexol is an excellent marker of glomerular filtration rate (GFR) and serves as a suitable alternative to radiotracers, which require special handling and disposal.

Iohexol Structure and Mechanism of Action

The chemical name of Iohexol is 5-[Acetyl(2,3-dihydroxypropyl)amino]-N1, N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide. Its chemical formula is C₁₉H₂₆I₃N₃O₉, and its molecular weight is approximately 821.1 g/mol.

Iohexol, with its high iodine content, enhances imaging during CT

examinations.

Iohexol Impurities and Synthesis

The control and analysis of impurities in Iohexol are vital to ensure its quality and safety as a contrast agent. They can originate from various sources, including the synthetic process¹ and storage conditions. It is essential to monitor and control impurities at every stage of preparation. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS) help in impurity profiling and quantification. Stringent quality control measures can meet regulatory standards and ensure the purity and safety of Iohexol. Regular testing and monitoring help minimize impurities and maintain the desired drug quality.

Daicel Pharma, in adherence to cGMP standards, operates an analytical facility where we prepare Iohexol impurity standards like EP IOHEXOL IMPURITY F/ Iohexol impurity F, EP IOHEXOL IMPURITY M/ Iohexol impurity M, IOHEXOL EP IMPURITY G/ Iohexol Impurity G, IOHEXOL EP IMPURITY H/ Iohexol Impurity H, and IOHEXOL EP IMPURITY I/ Iohexol Impurity I. We offer a comprehensive Certificate of Analysis (CoA) for these impurity standards, providing a detailed characterization report. The CoA includes data obtained through techniques, 1H NMR, 13C NMR, IR, MASS, and HPLC purity analysis². Upon request, we give additional data like 13C-DEPT. We can synthesize unknown Iohexol impurity standards or degradation products. Each delivery has a comprehensive characterization report.